Mental Health

While the overall effectiveness of collaborative care has been well established, this study aimed to determine which specific components had the most impact.

While the prevention program worked as intended in White American youth, Black youth participants did not have success with the same program.

Areas for further research suggested by Xin Hu, PhD, MSPH, include examining differences in telemental health uptake between new and existing patients and exploring how these differences vary across demographic subgroups.

Incorporating dynamic pricing into cost-effectiveness analysis could offer significant benefits for equity in health care.

Xin Hu, PhD, MSPH, hypothesizes that these telemental health disparities could be driven by language barriers, historical mistrust, and systemic challenges.

The authors argue that the stimulant shortage is being perpetuated by the overdiagnosis of attention-deficit/hyperactivity disorder (ADHD) in adults because executive functioning deficits are not included in diagnostic criteria.

Medication-assisted treatment is an excellent approach to managing addiction and related emotional symptoms, Rachel Rohaidy, MD, of Miami Neuroscience Institute with Baptist Health, explains.

Despite a surge in telemental health use after the onset of the COVID-19 pandemic, minority racial/ethnic group children had lower utilization rates than White children, according to Xin Hu, PhD, MSPH.

Rachel Rohaidy, MD, of Miami Neuroscience Institute with Baptist Health, shares how she offers a personalized approach to treating substance use disorder in high-functioning patients.

The large UK Biobank study finds depression a significant risk predictor for developing chronic conditions such as osteoarthritis, hypertension, and gastro-oesophageal reflux disease.

Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, outlines the progression of treatment approaches for comorbid schizophrenia and substance use disorder.

The number of psychiatrists submitting more than 10 claims to Medicare Part B decreased by 16.8% from 2014 to 2022.

Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, discusses the bidirectional relationship between schizophrenia and substance use disorders in an interview.

Prolonged immigration detention is significantly associated with worsened self-rated health, along with high rates of posttraumatic stress disorder (PTSD) and mental illness.

Researchers suspect unmet treatment needs contribute to the shorter life expectancy for patients living with attention-deficit/hyperactivity disorder (ADHD).

Esketamine (Spravato; Johnson & Johnson) is now the first and only monotherapy for adults with major depressive disorder (MDD) with inadequate response to at least 2 oral antidepressants.

Among publicly insured children with mental health–related encounters, racial and ethnic disparities in telemental health use widened following the onset of the COVID-19 pandemic.

The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.

ACA enrollment rate hits a milestone, though IRA subsidies may not extend beyond 2025; network adequacy standards fail to translate into efficient access to mental health care for Medicaid enrollees; research examines racial disparities in postpartum hypertension and vaccine uptake.

Doctors conducted suicide risk assessments for 42% of patients flagged by interruptive alerts, compared with only 4% with passive alerts.

Quantitative Medicaid managed care network adequacy standards were not associated with improved mental health (MH) care access among adults and those with MH conditions.

Sarah Ahmad, MBA, CEO of the Coalition for Affordable Quality Healthcare (CAQH), dives into the financial, physical, and emotional toll of neglecting women's health in an interview.

The most-read articles addressing mental health in 2024 spanned therapeutic advancements, research discoveries, and insight into enhanced practice guidelines.

Despite promising outcomes for certain conditions, use of psychedelics and MDMA-assisted therapies are associated with risks, especially as treatment use expands beyond controlled clinical settings.

Discover strategies for identifying, treating, and supporting those affected by seasonal affective disorder (SAD).

The Center on Health Equity & Access highlights news and expert insights on research, social determinants of health, and health policy.

While name brands like Adderall and Vyvanse may have been recently removed from the FDA Drug Shortage Database, it's unclear if it'll last; meanwhile, many generic forms of attention-deficit/hyperactivity disorder (ADHD) medication are still in short supply.

The upcoming Greater Philadelphia Business Coalition on Health (GPBCH) 2024 Mental Health Summit aims to address the growing recognition among employers of the critical role mental health plays in workplace productivity and overall well-being.

Adults currently aging into Medicare utilized counseling and psychotherapy services at higher rates than those in prior cohorts at the same age.

There are significant financial and psychological burdens of abortion care in the US, especially for those traveling out of state due to local restrictions in the increasingly restrictive post-Dobbs landscape.